GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: E7070
Compound class:
Synthetic organic
Comment: Indisulam is an anticancer sulfonamide that is in clinical development. This compound belongs to the family of carbonic anhydrase inhibitors. It also behaves as a type of molecular glue that targets certain proteins for ubiquitination and proteasomal degradation [1,3], by bringing them into the proximity the CUL4-DDB1-DDA1-DCAF15 E3 ubiquitin ligase complex.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| Selectivity at enzymes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
| Targets where the ligand is described in the comment field | |
| Target | Comment |
|
RNA binding motif protein 39 in Spliceosome proteins RNA binding motif protein 39 in RNA-binding proteins (RBPs) |
The RBM39 protein is a spliceosome component that has roles in steroid hormone receptor-mediated transcription and alternative splicing. It is a target of pharmaceutical interest based on its ability to modulate the alternative splicing of genes involved in cancer occurrence and progression. The aryl sulfonamides indisulam and tasisulam have been identified as molecular glue class degraders of RBM39. Next-generation RBM39 molecular glue degraders are in development pipelines, including REC-1245 (Recursion; phase 1/2 for advanced solid tumours), and ST-00937 and ST-01156 (Seed Therapeutics; for Ewing sarcoma and other solid tumours) - structures not disclosed as of September 2025. |